Geode Capital Management’s OKYO Pharma OKYO Stock Holding History

Geode Capital Management’s Portfolio OKYO Stock Details OKYO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$18.1K	Hold	12,090	–	–	﹤0.01%	4379
2026 Q1	$19.5K	Hold	12,090	–	–	﹤0.01%	4451
2025 Q4	$25K	Hold	12,090	–	–	﹤0.01%	4354
2025 Q3	$24.2K	Hold	12,090	–	–	﹤0.01%	4399
2025 Q2	$31.1K	Hold	12,090	–	–	﹤0.01%	4296
2025 Q1	$15.4K	Hold	12,090	–	–	﹤0.01%	4397
2024 Q4	$13.9K	Hold	12,090	–	–	﹤0.01%	4416
2024 Q3	$12.5K	Hold	12,090	–	–	﹤0.01%	4450
2024 Q2	$14.7K	Hold	12,090	–	–	﹤0.01%	4502
2024 Q1	$18.1K	Hold	12,090	–	–	﹤0.01%	4493
2023 Q4	$21.5K	Hold	12,090	–	–	﹤0.01%	4506
2023 Q3	$22.4K	Buy	+12,090	New	+$20.3K	﹤0.01%	4602

Other funds holding OKYO

Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

SCM

Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return

Maven Securities St Helier, Jersey $5.06B AUM 59.27% 1-Year Est. Return

Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return

Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return

Choreo LLC Rockford, Illinois $9.11B AUM 26.3% 1-Year Est. Return

QCM

Quantinno Capital Management New York $83.3B AUM 37.97% 1-Year Est. Return

Cerity Partners New York $82.7B AUM 28.53% 1-Year Est. Return

Geode Capital Management's OKYO Position: Q2 2026 in Review

Geode Capital Management held its OKYO Pharma (OKYO) position steady in Q2 2026 at 12,090 shares worth $18.1K. The position accounts for ﹤0.01% of the portfolio, ranked #4379.

Geode Capital Management first reported a position in OKYO in Q3 2023 and has held it in 12 quarters since. The position peaked at $31.1K in Q2 2025. 19 funds tracked by Wall St. Rank hold OKYO as of Q2 2026.

Geode Capital Management held 12,090 shares of OKYO Pharma worth $18.1K as of Q2 2026.
Geode Capital Management left its OKYO Pharma share count unchanged in Q2 2026.
OKYO Pharma made up ﹤0.01% of Geode Capital Management's portfolio in Q2 2026, its #4379 holding.
Geode Capital Management first reported a position in OKYO Pharma in Q3 2023 and has held it in 12 quarters since.
Geode Capital Management's OKYO Pharma position peaked at $31.1K in Q2 2025.
19 funds tracked by Wall St. Rank held OKYO Pharma as of Q2 2026.

Based on Geode Capital Management's 13F filing for Q2 2026, filed 12 Aug 2026.